Certara enhances SYBYL-X drug design and discovery software suite

Certara has released version 2.1 of its SYBYL-X molecular modeling and simulation suite.

Register for free to listen to this article
Listen with Speechify

Certara has released version 2.1 of its SYBYL-X molecularmodeling and simulation suite. SYBYL-X 2.1 features a new job control systemthat provides a consistent interface across the entire tool suite. This changeallows jobs to be submitted remotely from Windows, Linux or Mac to any Linuxsystem where SYBYL-X is installed. Certara's QSAR technology is also moreaccessible now.


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN Magazine May 2024

Latest Issue  

• Volume 20 • Issue 3 • May 2024

May 2024

May 2024 Issue